PDS BiotechnologySTU:EU6 -1.38%31 PB Ratio is 11.93 as of Jul. 09, 2026. GuruFocus rates STU:EU6 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 1,226 Biotechnology companies, PDS Biotechnology ranks worse than 88.09% on this metric.
The historical rank and industry rank for PDS Biotechnology's PB Ratio or its related term are showing as below:
STU:EU6'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 11.74
Current: 11.74
During the past 13 years, PDS Biotechnology's highest PB Ratio was 11.74. The lowest was 0.00. And the median was 0.00.
STU:EU6's PB Ratio is ranked worse than 88.09% of 1226
companies
in the Biotechnology industry
Industry Median: 2.89
vs STU:EU6: 11.74
During the past 12 months, PDS Biotechnology's average Book Value Per Share Growth Rate was -66.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -51.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -34.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -45.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PDS Biotechnology was -13.00% per year. The lowest was -68.90% per year. And the median was -45.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PDS Biotechnology PB Ratio Related Terms
PDS Biotechnology PB Ratio Historical Data
* Premium members only.
The historical data trend for PDS Biotechnology's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, PDS Biotechnology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PDS Biotechnology PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PDS Biotechnology's PB Ratio distribution charts can be found below:
* The bar in red indicates where PDS Biotechnology's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PDS Biotechnology (STU:EU6) has a PB Ratio of 11.93 as of Jul. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PDS Biotechnology and its competitors. According to the industry distribution chart, PDS Biotechnology ranks #1080 out of 1226 companies in the Biotechnology industry, placing it in the top 88.1%.
Is PDS Biotechnology's PB Ratio too high?
PDS Biotechnology's current PB Ratio is 11.93. The Biotechnology industry median PB Ratio is 2.89. PDS Biotechnology's value of 11.93 is 312.8% above this industry median. Based on the distribution chart, PDS Biotechnology ranks #1080 out of 1226 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PDS Biotechnology has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's PB Ratio compare to LTRN and AURX?
According to the Biotechnology industry distribution chart, PDS Biotechnology ranks #1080 out of 1226 companies for PB Ratio. This places PDS Biotechnology in the lower half of its industry. The industry median PB Ratio is 2.89. PDS Biotechnology's value of 11.93 is 312.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.89, based on 1,226 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PDS Biotechnology's current PB Ratio of 11.93 is 312.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PDS Biotechnology and its competitors. For the Biotechnology industry, the median PB Ratio is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PDS Biotechnology's current PB Ratio is 11.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (STU:EU6) has a current PB Ratio of 11.93. The current PB Ratio is 11.93 and 312.8% above the Biotechnology industry median of 2.89. PDS Biotechnology's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For PDS Biotechnology (STU:EU6), the current PB Ratio is 11.93 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
31GF Score
Get the complete analysis for STU:EU6
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:EU6 has been successfully added to your 
